Bioinformatics Analysis to Reveal Potential Targets of Huntington's Disease
- 1Institute of Clinical Medicine State Key Laboratory of Complex Severe and Rare Diseases Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China
- 2Department of Cardiology Peking Union Medical College Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Beijing China
Abstract
Huntington's disease (HD) is a progressive neurodegenerative disease resulted from the expansion of CAG repeats in huntingtin (HTT) gene and characterised by motor impairment, psychiatric disorders and cognitive decline. Currently, there are no available disease‐modifying treatments. In this study, we performed an integrative analysis of HD datasets downloaded from the Gene Expression Omnibus (GEO) database using machine learning approaches, Mendelian randomisation (MR) and single cell RNA‐sequencing (scRNA‐seq) analysis to elucidate underlying disease mechanisms. The machine learning algorithms of LASSO, random forest and SVM‐RFE identified the decreased ADRA2A in HD. In addition, MR analysis revealed HD‐associated proteins such as LILRA4 and UBE2D1, associated with immune response and ubiquitination metabolism, respectively. scRNA‐seq analysis further identified the transcription factors of SOX4 and ETV1 through SCENIC analysis. Pseudotime trajectory analysis highlighted heparan sulphate sulfotransferase activity, involving genes CHST11, HS3ST3A1 and HS6ST3 that drive cell differentiation. Moreover, cell‐cell communication analysis demonstrated enhanced NRG1/3‐ERBB4 signalling pathway in HD. This study presents multiple potential targets for HD treatment but further experimental validation is required to confirm their functional relevance.
Related
- The potential of AI inspired approaches for patient monitoring in drug development for Huntington's disease: capturing the digital exhaust for activities of daily living.
- Hyperhomocysteinemia and Vitamin B Deficiency as Potential Aggravating Factors in Huntington's Disease: A Prospective Monocentric Study
- Sleep Spindles and Slow Oscillations as Potential Biomarkers and Therapeutic Targets in Mild-to-Moderate Alzheimer's Disease.
- Multivariate Genomic Analysis Reveals Shared Genetic Architecture and Potential Therapeutic Targets for Atherosclerotic Cardiovascular Disease
- The human-specific lncRNA HD-LINC drives lipid droplet-associated neurodegeneration in Huntington's disease
BibTeX
@article{yang2026bioinformatics,
title = {{Bioinformatics Analysis to Reveal Potential Targets of Huntington's Disease}},
author = {Shu Yang and Xinjie Xu and Weida Liu and Shuyang Zhang},
journal = {IET Systems Biology},
year = {2026},
month = nov,
doi = {10.1049/syb2.70088},
url = {https://doi.org/10.1049/syb2.70088},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Bioinformatics Analysis to Reveal Potential Targets of Huntington's Disease
AU - Shu Yang
AU - Xinjie Xu
AU - Weida Liu
AU - Shuyang Zhang
PY - 2026
DA - 2026/11/01
JO - IET Systems Biology
DO - 10.1049/syb2.70088
UR - https://doi.org/10.1049/syb2.70088
AB - Huntington's disease (HD) is a progressive neurodegenerative disease resulted from the expansion of CAG repeats in huntingtin (HTT) gene and characterised by motor impairment, psychiatric disorders and cognitive decline. Currently, there are no available disease‐modifying treatments. In this study, we performed an integrative analysis of HD datasets downloaded from the Gene Expression Omnibus (GEO) database using machine learning approaches, Mendelian randomisation (MR) and single cell RNA‐sequencing (scRNA‐seq) analysis to elucidate underlying disease mechanisms. The machine learning algorithms of LASSO, random forest and SVM‐RFE identified the decreased ADRA2A in HD. In addition, MR analysis revealed HD‐associated proteins such as LILRA4 and UBE2D1, associated with immune response and ubiquitination metabolism, respectively. scRNA‐seq analysis further identified the transcription factors of SOX4 and ETV1 through SCENIC analysis. Pseudotime trajectory analysis highlighted heparan sulphate sulfotransferase activity, involving genes CHST11, HS3ST3A1 and HS6ST3 that drive cell differentiation. Moreover, cell‐cell communication analysis demonstrated enhanced NRG1/3‐ERBB4 signalling pathway in HD. This study presents multiple potential targets for HD treatment but further experimental validation is required to confirm their functional relevance.
SN - 1751-8849
SN - 1751-8857
ER -